Good_老虎社区_美港股上老虎

2021-07-19

Good

Valneva, Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":173525573,"tweetId":"173525573","gmtCreate":1626672186092,"gmtModify":1631893546551,"author":{"id":3567308634822078,"idStr":"3567308634822078","authorId":3567308634822078,"authorIdStr":"3567308634822078","name":"doky","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good</p></body></html>","htmlText":"<html><head></head><body><p>Good</p></body></html>","text":"Good","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/173525573","repostId":2152636693,"repostType":4,"repost":{"id":"2152636693","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626670971,"share":"https://www.laohu8.com/m/news/2152636693?lang=&edition=full","pubTime":"2021-07-19 13:02","market":"us","language":"en","title":"Valneva, Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2152636693","media":"T-Reuters","summary":"Valneva SE:Valneva And Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candida","content":"<p><a href=\"https://laohu8.com/S/VNVLF\">Valneva SE</a>:Valneva And Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate.Have Completed Recruitment For Phase 2 Trial, Vla15-221, Of Lyme Disease Vaccine Candidate, Vla15.Trial Builds On Previous Positive Phase 2 Trials And Includes Both Adult And Pediatric Participants.Main Safety And Immunogenicity Readout Will Be Performed Approximately One Month After Completion Of Primary Vaccination Schedule.Objective Of Trial Is To Show Safety And Immunogenicity Down To 5 Years Of Age And To Evaluate Optimal Vaccination Schedule For Use In Phase 3.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Valneva, Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nValneva, Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-19 13:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/VNVLF\">Valneva SE</a>:Valneva And Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate.Have Completed Recruitment For Phase 2 Trial, Vla15-221, Of Lyme Disease Vaccine Candidate, Vla15.Trial Builds On Previous Positive Phase 2 Trials And Includes Both Adult And Pediatric Participants.Main Safety And Immunogenicity Readout Will Be Performed Approximately One Month After Completion Of Primary Vaccination Schedule.Objective Of Trial Is To Show Safety And Immunogenicity Down To 5 Years Of Age And To Evaluate Optimal Vaccination Schedule For Use In Phase 3.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152636693","content_text":"Valneva SE:Valneva And Pfizer Complete Recruitment For Phase 2 Trial Of Lyme Disease Vaccine Candidate.Have Completed Recruitment For Phase 2 Trial, Vla15-221, Of Lyme Disease Vaccine Candidate, Vla15.Trial Builds On Previous Positive Phase 2 Trials And Includes Both Adult And Pediatric Participants.Main Safety And Immunogenicity Readout Will Be Performed Approximately One Month After Completion Of Primary Vaccination Schedule.Objective Of Trial Is To Show Safety And Immunogenicity Down To 5 Years Of Age And To Evaluate Optimal Vaccination Schedule For Use In Phase 3.","news_type":1},"isVote":1,"tweetType":1,"viewCount":175,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/173525573"}